B. Metzler Seel. Sohn & Co. Holding Ag Astrazeneca PLC Transaction History

B. Metzler Seel. Sohn & Co. Holding Ag

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$76.67 - $87.62 $2.81 Million - $3.21 Million	-36,658 Closed	0 $0
Q2 2021 Aug 30, 2021	SELL	$48.42 - $60.18 $159,737 - $198,533	-3,299 Reduced 8.26%	36,658 $2.2 Million
Q4 2020 Mar 08, 2021	BUY	$48.52 - $58.02 $1.94 Million - $2.32 Million	39,957 New	39,957 $2 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of B. Metzler Seel. Sohn & Co. Holding Ag, based on Form 13F filings with the SEC.

Stay updated on B. Metzler Seel. Sohn & Co. Holding Ag with notifications on news.